| An interactive resource to identify cancer genetic and lineage dependencies targeted by small molecules A Basu, NE Bodycombe, JH Cheah, EV Price, K Liu, GI Schaefer, ... Cell 154 (5), 1151-1161, 2013 | 804 | 2013 |
| Hdac3 is essential for the maintenance of chromatin structure and genome stability S Bhaskara, SK Knutson, G Jiang, MB Chandrasekharan, AJ Wilson, ... Cancer cell 18 (5), 436-447, 2010 | 406 | 2010 |
| Gynecologic cancer disparities: a report from the Health Disparities Taskforce of the Society of Gynecologic Oncology Y Collins, K Holcomb, E Chapman-Davis, D Khabele, JH Farley Gynecologic oncology 133 (2), 353-361, 2014 | 252 | 2014 |
| Blueprints obstetrics and gynecology T Callahan, AB Caughey Lippincott Williams & Wilkins, 2013 | 177 | 2013 |
| BET bromodomain inhibition synergizes with PARP inhibitor in epithelial ovarian cancer S Karakashev, H Zhu, Y Yokoyama, B Zhao, N Fatkhutdinov, ... Cell reports 21 (12), 3398-3405, 2017 | 176 | 2017 |
| Drug-induced inactivation or gene silencing of class I histone deacetylases suppresses ovarian cancer cell growth: implications for therapy D Khabele, DS Son, AK Parl, GL Goldberg, LH Augenlicht, ... Cancer biology & therapy 6 (5), 795-801, 2007 | 132 | 2007 |
| Suberoylanilide hydroxamic acid (SAHA) enhances olaparib activity by targeting homologous recombination DNA repair in ovarian cancer PA Konstantinopoulos, AJ Wilson, J Saskowski, E Wass, D Khabele Gynecologic oncology 133 (3), 599-606, 2014 | 127 | 2014 |
| Challenging US apartheid: Atlanta and black struggles for human rights, 1960–1977 WA Grady-Willis Duke University Press, 2020 | 120 | 2020 |
| The clinicopathologic significance of p53 and BAF-250a (ARID1A) expression in clear cell carcinoma of the endometrium O Fadare, K Gwin, MM Desouki, MA Crispens, HW Jones III, D Khabele, ... Modern pathology 26 (8), 1101-1110, 2013 | 114 | 2013 |
| Inhibition of histone deacetylase 3 causes replication stress in cutaneous T cell lymphoma CE Wells, S Bhaskara, KR Stengel, Y Zhao, B Sirbu, B Chagot, D Cortez, ... PloS one 8 (7), e68915, 2013 | 112 | 2013 |
| Keratinocyte chemoattractant (KC)/human growth-regulated oncogene (GRO) chemokines and pro-inflammatory chemokine networks in mouse and human ovarian epithelial cancer cells DS Son, AK Parl, V Montgomery Rice, D Khabele Cancer biology & therapy 6 (8), 1308-1318, 2007 | 111 | 2007 |
| The BET inhibitor INCB054329 reduces homologous recombination efficiency and augments PARP inhibitor activity in ovarian cancer AJ Wilson, M Stubbs, P Liu, B Ruggeri, D Khabele Gynecologic oncology 149 (3), 575-584, 2018 | 103 | 2018 |
| Histone deacetylase inhibitors enhance the chemosensitivity of tumor cells with cross‐resistance to a wide range of DNA‐damaging drugs K Ozaki, F Kishikawa, M Tanaka, T Sakamoto, S Tanimura, M Kohno Cancer science 99 (2), 376-384, 2008 | 96 | 2008 |
| Morphologic and other clinicopathologic features of endometrial clear cell carcinoma: a comprehensive analysis of 50 rigorously classified cases O Fadare, W Zheng, MA Crispens, W Howard III, D Khabele, K Gwin, ... American journal of cancer research 3 (1), 70, 2013 | 88 | 2013 |
| Comparative analysis of Napsin A, alpha-methylacyl-coenzyme A racemase (AMACR, P504S), and hepatocyte nuclear factor 1 beta as diagnostic markers of ovarian clear cell … O Fadare, C Zhao, D Khabele, V Parkash, CM Quick, K Gwin, ... Pathology 47 (2), 105-111, 2015 | 87 | 2015 |
| Bipolar tumor-associated macrophages in ovarian cancer as targets for therapy V Gupta, F Yull, D Khabele Cancers 10 (10), 366, 2018 | 86 | 2018 |
| A call to action: Black/African American women surgeon scientists, where are they? C Berry, D Khabele, C Johnson-Mann, R Henry-Tillman, KA Joseph, ... Annals of surgery 272 (1), 24-29, 2020 | 78 | 2020 |
| In vivo ultrasonic attenuation slope estimates for detecting cervical ripening in rats: Preliminary results TA Bigelow, BL McFarlin, WD O’Brien, ML Oelze The Journal of the Acoustical Society of America 123 (3), 1794-1800, 2008 | 76 | 2008 |
| Thymoquinone enhances cisplatin-response through direct tumor effects in a syngeneic mouse model of ovarian cancer AJ Wilson, J Saskowski, W Barham, F Yull, D Khabele Journal of ovarian research 8, 1-10, 2015 | 70 | 2015 |
| Pharmaceutical perspectives of cancer therapeutics Y Lu, RI Mahato Springer Science & Business Media, 2009 | 69 | 2009 |
Oluwole FadareUniversity of California San DiegoVerifierad e-postadress på ucsd.edu
